The Effects of Cognitive Therapy Versus ‘Treatment as Usual’ in Patients with Major Depressive Disorder
Open accessThe DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Major depressive disorder afflicts an estimated 17% of individuals during their lifetimes at tremendous suffering and costs. Cognitive therapy may be an effective treatment option for major depressive disorder, but the effects have only had limited assessment in systematic reviews. METHODS/PRINCIPAL FINDINGS: Cochrane systematic review methodology, with meta-analyses and trial sequential analyses of randomized trials, are comparing the effects of cognitive therapy versus 'treatment as usual' for major depressive disorder. To be included the participants had to be older than 17 years with a primary diagnosis of major depressive disorder. Altogether, we included eight trials randomizing a total of 719 participants. All eight trials had high risk of bias. Four trials reported data on the 17-item Hamilton Rating Scale for Depression and four trials reported data on the Beck Depression Inventory. Meta-analysis on the data from the Hamilton Rating Scale for Depression showed that cognitive therapy compared with 'treatment as usual' significantly reduced depressive symptoms (mean difference -2.15 (95% confidence interval -3.70 to -0.60; P<0.007, no heterogeneity)). However, meta-analysis with both fixed-effect and random-effects model on the data from the Beck Depression Inventory (mean difference with both models -1.57 (95% CL -4.30 to 1.16; P = 0.26, I(2) = 0) could not confirm the Hamilton Rating Scale for Depression results. Furthermore, trial sequential analysis on both the data from Hamilton Rating Scale for Depression and Becks Depression Inventory showed that insufficient data have been obtained. DISCUSSION: Cognitive therapy might not be an effective treatment for major depressive disorder compared with 'treatment as usual'. The possible treatment effect measured on the Hamilton Rating Scale for Depression is relatively small. More randomized trials with low risk of bias, increased sample sizes, and broader more clinically relevant outcomes are needed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Wood, L., Egger, M., Gluud, L. L., Schulz, K. F., Jüni, P., Altman, D. G., Gluud, C., Martin, R. M., Wood, A. J. G., & Sterne, J. A. C. (2008) · BMJ · doi:10.1136/bmj.39465.451748.ad · Cited by 2,538 · cited 1×
“This classification is important because trials with ‘high risk of bias’ may overestimate positive intervention effects and underestimate negative intervention effects [15,27,28,30], and we wanted to relate the validity of our results to the risk of bias in the included trials.”
ResultSelf-citationKirsch, I., Deacon, B. J., Huedo-Medina, T. B., Scoboria, A., Moore, T. J., & Johnson, B. T. (2008) · PLoS Medicine · doi:10.1371/journal.pmed.0050045 · Cited by 2,442
Selective publication of antidepressant trials and its influence on apparent efficacy
Turner, E. H., Matthews, A. M., Linardatos, E., Tell, R. A., & Rosenthal, R. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa065779 · Cited by 2,435
Elkin, I. (1989) · Archives of General Psychiatry · doi:10.1001/archpsyc.1989.01810110013002 · Cited by 2,300 · cited 1×
“We included 18 publications [79–96] on eight trials [14,79– 82,84,85,97] randomizing a total of 719 participants (see Figure S1).”
BackgroundBoutron, I., Moher, D., Altman, D. G., Schulz, K. F., Ravaud, P., & for the CONSORT Group* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-4-200802190-00008 · Cited by 2,292
Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis
Wetterslev, J., Thorlund, K., Brok, J., & Gluud, C. (2008) · Journal of Clinical Epidemiology · doi:10.1016/j.jclinepi.2007.03.013 · Cited by 1,881
Self-citationDimidjian, S., Hollon, S. D., Dobson, K. S., Schmaling, K. B., Kohlenberg, R. J., Addis, M. E., Gallop, R., McGlinchey, J. B., Markley, D. K., Gollan, J. K., et al. (2006) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.74.4.658 · Cited by 1,607
Psychological debriefing for preventing post traumatic stress disorder (PTSD)
Rose, S. C., Bisson, J., Churchill, R., & Wessely, S. (2002) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd000560 · Cited by 1,250
The Hamilton Depression Rating Scale: Has the Gold Standard Become a Lead Weight?
Bagby, R. M., Ryder, A. G., Schuller, D. R., & Marshall, M. B. (2004) · American Journal of Psychiatry · doi:10.1176/appi.ajp.161.12.2163 · Cited by 1,148
Cognitive Therapy vs Medications in the Treatment of Moderate to Severe Depression
DeRubeis, R. J., Hollon, S. D., Amsterdam, J. D., Shelton, R. C., Young, P. R., Salomon, R. M., O’Reardon, J. P., Lovett, M. L., Gladis, M. M., Brown, L. L., et al. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.4.409 · Cited by 989 · cited 5×
“We classified the therapists’ level of experience and/or education in three trials as ‘high’ [14,79,81], in two trials as ‘intermediate’ [84,85], and in the last three as ‘unclear’ [80,82,97].”
BackgroundInfluentialRelapse prevention with antidepressant drug treatment in depressive disorders: a systematic review
Geddes, J. R., Carney, S. M., Davies, C., Furukawa, T. A., Kupfer, D. J., Frank, E., & Goodwin, G. M. (2003) · The Lancet · doi:10.1016/s0140-6736(03)12599-8 · Cited by 945 · cited 1×
“Antidepressants might, however, decrease the risk of relapse [11].”
BackgroundBias in clinical intervention research.
Gluud, L. L. (2006) · American Journal of Epidemiology · doi:10.1093/aje/kwj069 · Cited by 636
(1991) · American Journal of Psychiatry · doi:10.1176/ajp.148.8.997 · Cited by 580
Dobson, K. S., Hollon, S. D., Dimidjian, S., Schmaling, K. B., Kohlenberg, R. J., Gallop, R. J., Rizvi, S. L., Gollan, J. K., Dunner, D. L., & Jacobson, N. S. (2008) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.76.3.468 · Cited by 560
Vittengl, J. R., Clark, L. A., Dunn, T. W., & Jarrett, R. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.475 · Cited by 551
Spijker, J., De Graaf, R., Bijl, R. V., Beekman, A. T. F., Ormel, J., & Nolen, W. A. (2002) · British Journal of Psychiatry · doi:10.1192/bjp.181.3.208 · Cited by 514
Cognitive Therapy and Pharmacotherapy for Depression: Singly and in Combination
Hollon, S. D. (1992) · Archives of General Psychiatry · doi:10.1001/archpsyc.1992.01820100018004 · Cited by 481 · cited 1×
“Further 42 publications [37–78] were excluded because the trial participants or the interventions did not meet our in-”
BackgroundMindfulness-based cognitive therapy as a treatment for chronic depression: A preliminary study
Barnhofer, T., Crane, C., Hargus, E., Amarasinghe, M., Winder, R., & Williams, J. M. G. (2009) · Behaviour Research and Therapy · doi:10.1016/j.brat.2009.01.019 · Cited by 396
Davidson, K. W., Rieckmann, N., Clemow, L., Schwartz, J. E., Shimbo, D., Medina, V., Albanese, G., Kronish, I., Hegel, M., & Burg, M. M. (2010) · Archives of Internal Medicine · doi:10.1001/archinternmed.2010.29 · Cited by 350 · cited 1×
“These exclusions were conducted because we expect participants in such trials to respond differently to standardized psychotherapy than other depressed patients, and these types of depressed patients are traditionally examined in separate trials [23–26].”
BackgroundMode-specific effects among three treatments for depression.
Imber, S. D., Pilkonis, P. A., Sotsky, S. M., & Elkin, I. (1990) · Journal of Consulting and Clinical Psychology · doi:10.1037//0022-006x.58.3.352 · Cited by 330
Wright, J. H., Wright, A. S., Albano, A. M., Basco, M. R., Goldsmith, L. J., Raffield, T., & Otto, M. W. (2005) · American Journal of Psychiatry · doi:10.1176/appi.ajp.162.6.1158 · Cited by 319
Horowitz, J. L., Garber, J., Ciesla, J. A., Young, J. F., & Mufson, L. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.5.693 · Cited by 236
Escitalopram versus other antidepressive agents for depression
Cipriani, A., Santilli, C., Furukawa, T. A., Signoretti, A., Nakagawa, A., McGuire, H., Churchill, R., & Barbui, C. (2009) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006532.pub2 · Cited by 190
Walwyn, R., & Roberts, C. (2010) · Statistical Methods in Medical Research · doi:10.1177/0962280209105017 · Cited by 93 · cited 1×
“Factors like personal style, communication skills, and personality of the therapist evidently will influence the way psychotherapy is delivered [104].”
BackgroundRohan, K. J., Roecklein, K. A., Tierney Lindsey, K., Johnson, L. G., Lippy, R. D., Lacy, T. J., & Barton, F. B. (2007) · Journal of Consulting and Clinical Psychology · doi:10.1037/0022-006x.75.3.489 · Cited by 87
Wong, D. F. K. (2008) · Depression and Anxiety · doi:10.1002/da.20286 · Cited by 66 · cited 1×
“Further 42 publications [37–78] were excluded because the trial participants or the interventions did not meet our in-”
Background
Cited by
Non-pharmacological treatment of depression: a systematic review and evidence map
Farah, W. H., Alsawas, M., Mainou, M., Alahdab, F., Farah, M. H., Ahmed, A. T., Mohamed, E. A., Almasri, J., Gionfriddo, M. R., Castaneda-Guarderas, A., et al. (2016) · Evidence Based Medicine · doi:10.1136/ebmed-2016-110522 · Cited by 141
Treating depression With Tai Chi: state of the art and future perspectives
Kong, J., Wilson, G., Park, J., Pereira, K., Walpole, C., & Yeung, A. (2019) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2019.00237 · Cited by 75
Hansen, H. V., Christensen, E. M., Dam, H., Gluud, C., Wetterslev, J., Kessing, L. V., & the Early Intervention Affective Disorders (EIA) Trial Group (2012) · PLoS ONE · doi:10.1371/journal.pone.0032950 · Cited by 20
Self-citation
Metadata
- Authors
- Jakobsen, J. C., Lindschou Hansen, J., Storebø, O. J., Simonsen, E., & Gluud, C.
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2011-08-04
- Volume
- 6
- Issue
- 8
- Pages
- e22890
- ISSN
- 1932-6203 (ISSN-L)
- OpenAlex
- W2036629242
- Cited by
- 35
- References
- 26
- FWCI
- 6.72
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.